More on OPK

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+63.2% Growth)
- Ratings (5.5 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/30/26)
- M&A (12/31/16 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

OPK Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 144.65M
Marketable securities
Accounts receivable, net 223.83M
Inventory, net 43.19M
Prepaid expenses and other current assets 90.41M
Total current assets 502.07M
Property and equipment, net 125.49M
Intangible assets, net 781.89M
Goodwill 700.53M
Investments 38.78M
Other assets 4.31M
Total assets 2.8B
Accounts payable 58.54M
Accrued expenses 186.08M
Current portion of lines of credit
Total current liabilities 254.51M
Long-term liabilities 440.12M
Total liabilities 694.64M
Commitments and contingencies
Series D preferred stock - $0.01 par value, 2,000,000 shares authorized; 1,209,677 shares issued and outstanding (liquidation value of $34,213 and $33,013) at June 30, 2011 and December 31, 2010, respectively
Shareholders' equity
Common Stock - $0.01 par value, 500,000,000 shares authorized; 287,946,324 and 255,412,706 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively 5.58M
Treasury stock - 2,443,894 and 45,154 shares at June 30, 2011 and December 31, 2010, respectively -1.91M
Additional paid-in capital 2.83B
Accumulated other comprehensive income -16.28M
Accumulated deficit -716.29M
Total shareholders' equity
Total liabilities, Series D preferred stock, and Shareholders' equity 2.8B
Shareholders' equity
Preferred stock
Shareholders' equity
Preferred stock